APA (7th ed.) Citation

A, S., K, J., GF, P., & JC, C. (2026). From immunomodulators (IMiDs) to cereblon E3 ligase modulator (CELMoDs): The evolution of cereblon modulators in lymphoma therapy. Leukemia & lymphoma, 67(7), 1479. https://doi.org/10.1080/10428194.2026.2662494

Chicago Style (17th ed.) Citation

A, Saha, Jhaveri K, Perini GF, and Chavez JC. "From Immunomodulators (IMiDs) to Cereblon E3 Ligase Modulator (CELMoDs): The Evolution of Cereblon Modulators in Lymphoma Therapy." Leukemia & Lymphoma 67, no. 7 (2026): 1479. https://doi.org/10.1080/10428194.2026.2662494.

MLA (9th ed.) Citation

A, Saha, et al. "From Immunomodulators (IMiDs) to Cereblon E3 Ligase Modulator (CELMoDs): The Evolution of Cereblon Modulators in Lymphoma Therapy." Leukemia & Lymphoma, vol. 67, no. 7, 2026, p. 1479, https://doi.org/10.1080/10428194.2026.2662494.